Leukemia |
CD34+CD38- |
(Leong et al., 2017) |
Breast cancer |
CD44+/ESA+/CD24−/ALDH1+/ ABCG2+/ EpCAM+/CXCR4 |
(Hermawan & Putri, 2018) |
Brain tumour |
CD133+/ CD90+/ ALDH1+ |
(Kaur et al.,
2018) |
Pancreatic cancer |
CD44+/CD24+/ESA+/ CD133+/Bmi1/ALDH1+/ABCG2+/ CXCR4 |
(S.-H. Li et al., 2013) |
Colon cancer |
CD133+/ALDH1+/CD44+/EpCAM |
(Soltanian et al.,
2018) |
Liver cancer |
CD133+/CD90+/ CD44+/ ABCG2+/ EpCAM+/CD13+ |
(Yen et al.,
2018) |
Prostate cancer |
CD44+/CD133+/ ALDH1+/ Bmi1 |
(Kamalidehghan et al.,
2015) |
Lung cancer |
CD133+/CD117+/ ALDH1+/ ABCG2+/EpCAM |
(Bhummaphan et al.,
2019) |
Ovarian cancer |
CD133+/CD44+/CD117+/ALDH1+/ ABCG2+ |
(Torquato et al.,
2017) |
Stomach cancer |
CD44+/CD133+ |
(Oh et al., 2016) |
Nasopharyngeal cancer |
CD44+/CD133+/ALDH1+/ ABCG2+/ Bmi1 |
(S.-C. Liu
et al., 2019) |
Renal cancer |
CD105+ |
(Kaur et al., 2018) |
Oral cancer |
CD44+/ ALDH1+/CD117+/ Bmi1 |
(Lin et al.,
2018) |
Melanoma |
ABCB5+/ ALDH1+/ CD133+/CD44+/CD117+ |
(Jobani et al.,
2018) |
Glioblastoma |
CD133+/CD44+/ Bmi1 |
(Su et al., 2019) |